Policy Indications: India’s Impending Growth in Education and Skills Market: A Report  |  Technology Inceptions: Strong Soft Materials are on the Move!  |  Rajagiri Round Table: Learning Through Games-Art and Science of Serious Games  |  Science Innovations: How Nucleoli Exist as Stable Droplets within the Nucleus?  |  Career News: Indian School of Business Inviting application for Aspiring Entrepreneurs  |  Health Monitor: Early Diagnosis and Treatment of Autism Spectrum Disorder Effective  |  Health Monitor: “School Meal Coalition” an Initiative by the UN  |  Policy Indications: WHO’s #HealthyAtHome Challenge for Students  |  Science Innovations: Another Planet Discovery!  |  Higher Studies: Hebrew University of Jerusalem's International Med-Tech Innovation MBA  |  Higher Studies: University of Birmingham Dubai invites applications for M.Sc. Urban Planning  |  Leadership Instincts: UNICEF’s comprehensive statistical analysis finds that nearly 240 million childr  |  Technology Inceptions: Quantum Dots can be Improvised in Tracking Biochemical Pathways of a Drug  |  Technology Inceptions: MIT promotes ‘Back to Bicycles’ with Artificial Intelligence  |  Policy Indications: Cambridge’s New Curriculum matches NEP 2020  |  
October 29, 2021 Friday 11:53:19 AM IST

A new RNA-based control switch to trigger production of therapeutic proteins

Researchers at MIT and Harvard University have developed a new way to selectively turn on gene therapies in target cells, including human cells. The devised technology can detect specific messenger RNA sequences in cells, the detection then triggers production of a specific protein from a transgene, or artificial gene. The transgenes can have dangerous effects when expressed in the wrong cells. One way of distinguishing different types of cells is by reading the RNA sequences inside them, which is different from tissue to tissue. By finding a way to produce transgene only after “reading” specific RNA sequences inside cells, the researchers developed a technology that could fine-tune gene therapies in applications ranging from regenerative medicine to cancer treatment. The study was performed in cells grown in a lab dish. The researchers are currently working on delivery strategies that would allow the RNA components of the system to reach target cells in animal models.